Highland Therapeutics rakes in $25 mln from private equity investor
Canadian specialty pharmaceuticals company Highland Therapeutics Inc has raised US$25 million in follow-on financing. The deal was led by an unnamed private equity partner. Update: The Toronto-based company said that proceeds will be used to conduct clinical development and study of its lead drug product candidates, expand manufacturing capacity and pursue pipeline expansion opportunities. Highland Therapeutics is a client of Canadian innovation hub MaRS Discovery District.
16 October 2014•3 mins read
